These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 761394)

  • 21. Reverse-phase liquid chromatography and pharmacokinetic study of two hydroxylated analogues of quinidine in dogs.
    Leroyer R; Jarreau C; Pays M; Varoquaux O; Advenier C
    J Pharm Sci; 1984 Jun; 73(6):844-6. PubMed ID: 6547483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automatic solid-phase extraction and high-performance liquid chromatographic determination of quinidine in plasma.
    Brandsteterová E; Romanová D; Králiková D; Bozeková L; Kriska M
    J Chromatogr A; 1994 Apr; 665(1):101-4. PubMed ID: 8205229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the quinidine analog, 7'-trifluoromethyldihydrocinchonidine-2HCl in plasma and urine by high-performance liquid chromatography.
    Pao J; de Silva JA
    J Chromatogr; 1980 Nov; 221(1):97-108. PubMed ID: 7451629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific serum quinidine assay by high-performance liquid chromatography.
    Crouthamel WG; Kowarski B; Narang PK
    Clin Chem; 1977 Nov; 23(11):2030-3. PubMed ID: 912867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific high performance liquid chromatographic determination of quinidine in serum, blood, and urine.
    MacKichan JJ; Shields BJ
    Ther Drug Monit; 1987; 9(1):104-12. PubMed ID: 3576654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The estimation of quinidine in human plasma by ion pair extraction and high-performance liquid chromatography.
    Sved S; McGilveray IJ; Beaudoin N
    J Chromatogr; 1978 May; 145(3):437-44. PubMed ID: 659529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic method for the determination of quinine and 3-hydroxyquinine in blood samples dried on filter paper.
    Jansson A; Gustafsson LL; Mirghani RA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep; 795(1):151-6. PubMed ID: 12957180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-performance liquid chromatography of quinidine in plasma, with use of a microparticulate silica column.
    Peat MA; Jennison TA
    Clin Chem; 1978 Dec; 24(12):2166-8. PubMed ID: 719865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of quinine and quinidine in biological fluids by high performance liquid chromatography.
    Karbwang J; Na Bangchang K; Molunto P; Bunnag D
    Southeast Asian J Trop Med Public Health; 1989 Mar; 20(1):65-9. PubMed ID: 2772705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of quinidine in serum by spectrofluorometry, liquid chromatography and fluorescence scanning thin-layer chromatography.
    Vasiliades J; Finkel JM
    J Chromatogr; 1983 Nov; 278(1):117-32. PubMed ID: 6662869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of quinidine by fluorescence polarization immunoassay and high pressure liquid chromatography.
    Bridges RR; Smith CM; Jennison TA
    J Anal Toxicol; 1984; 8(4):161-3. PubMed ID: 6381883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
    Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
    Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
    Damkier P; Brøsen K
    Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous analysis of disopyramide and quinidine in plasma by high-performance liquid chromatography.
    Ahokas JT; Davies C; Ravenscroft PJ
    J Chromatogr; 1980 Jul; 183(1):65-71. PubMed ID: 7400265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis.
    Ha HR; Vozeh S; Follath F
    Ther Drug Monit; 1986; 8(3):331-5. PubMed ID: 3529516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinidine assays: enzyme immunoassay versus high performance liquid chromatography.
    Lehmann CR; Boran KJ; Pierson WP; Melikian AP; Wright GJ
    Ther Drug Monit; 1986; 8(3):336-9. PubMed ID: 3529517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.
    Drayer DE; Lowenthal DT; Restivo KM; Schwartz A; Cook CE; Reidenberg MM
    Clin Pharmacol Ther; 1978 Jul; 24(1):31-9. PubMed ID: 657716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum quinidine concentrations: comparison of fluorescence, gas-chromatographic, and gas-chromatographic/mass-spectrometric methods.
    Huffman DH; Hignite CE
    Clin Chem; 1976 Jun; 22(6):810-2. PubMed ID: 1277466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of quinidine analogs using ion-pairing HPLC.
    Al-Kaysi HN; Small LD; Murray WJ; Haddadin M
    J Chromatogr Sci; 1984 Feb; 22(2):80-3. PubMed ID: 6699121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.